Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oncology . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a scalable, high-yield synthesis of N-axis chiral indole amides with >95% ee and potent Hep G2 cytotoxicity. Reduce R&D costs and supply chain risks with our CDMO expertise.
Eliminate palladium catalysts and anhydrous conditions in vismodegib production. Achieve 99% purity with 50% yield using copper-catalyzed route. Reduce costs by 30%.
Solve hydrogenation and iron contamination issues in aminopyrimidine synthesis. Our CDMO expertise delivers high-yield, GMP-compliant production for non-small cell lung cancer therapeutics.
Struggling with low yields in fluorine intermediate synthesis? Discover emerging green processes achieving 75% yield and 98% purity for CDK4/6 inhibitors. Find reliable suppliers for mass production.
Struggling with low-yield entinostat synthesis? Discover emerging green chemistry routes for high-purity HDAC inhibitors. Find reliable API suppliers now.
Struggling with low yield and impurities in ibrutinib synthesis? Discover emerging mixed-base technology for high-purity API. Find reliable suppliers for scalable production.
Struggling with low yields in Gefitinib synthesis? Discover emerging high-purity, high-yield methods. Find reliable API suppliers for consistent production.